全球非酒精性脂肪性肝病发病率:63项研究及1,201,807人的系统评价与Meta分析
该系统评价与Meta分析纳入63项队列研究共1,201,807人,估算超声诊断的非酒精性脂肪性肝病(NAFLD)全球发病率为每10万人年4,612.8例(95%CI 3,931.5-5,294.2),男性、超重/肥胖者及吸烟者发病率更高,中国地区发病率高于非中国地区,日本低于非日本地区。
要点
- NAFLD全球发病率为每10万人年4,612.8例(95%CI 3,931.5-5,294.2)。
- 男性发病率高于女性(5,943.8 vs 3,671.7,p=0.0013)。
- 肥胖者较非肥胖者、超重/肥胖者较正常体重者发病风险约三倍。
核心结论
- NAFLD发病率正在上升,当前估计为每10万人年4,613例新发病例。
- 男性和超重/肥胖个体的发病率显著高于女性和正常体重者。
- 需要针对男性、超重/肥胖个体及高风险地区开展NAFLD预防的公共卫生干预。
研究设计与样本
- 系统评价与Meta分析,纳入63项基线无NAFLD成人的队列研究,共1,201,807人。
- 研究来自中国大陆/香港(n=26)、韩国(n=22)、日本(n=14)、其他(n=2,斯里兰卡、以色列);63.8%为临床中心研究;中位研究年份2000至2016年;87%为高质量。
主要发现
- 在1,201,807名风险人群中,242,568人发生NAFLD,发病率为每10万人年4,612.8例(95%CI 3,931.5-5,294.2)。
- 男性发病率高于女性(5,943.8 vs 3,671.7,p=0.0013)。
- 肥胖者较非肥胖者(8,669.6 vs 2,963.9)、超重/肥胖者较正常体重者(8,416.6 vs 3,358.2)发病风险约三倍(均p<0.0001)。
- 吸烟者发病率高于非吸烟者(8,043.2 vs 4,689.7,p=0.046)。
- 按国家,中国地区发病率高于非中国地区(p=0.012),日本低于非日本地区(p=0.005)。
关键数值与推荐
- NAFLD全球发病率为每10万人年4,612.8例(95%CI 3,931.5-5,294.2)。
- 男性发病率5,943.8 vs 女性3,671.7(p=0.0013)。
- 肥胖者8,669.6 vs 非肥胖者2,963.9;超重/肥胖者8,416.6 vs 正常体重者3,358.2(均p<0.0001)。
- 吸烟者8,043.2 vs 非吸烟者4,689.7(p=0.046)。
- 按研究样本量(p=0.90)或研究设置(p=0.055)发病率无统计学显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing. We aimed to estimate the pooled global NAFLD incidence. METHODS: We performed a systematic review and meta-analysis of cohort studies of adults without NAFLD at baseline to evaluate the global incidence of ultrasound-diagnosed NAFLD. RESULTS: A total of 63 eligible studies (1,201,807 persons) were analyzed. Studies were from Mainland China/Hong Kong (n = 26), South Korea (n = 22), Japan (n = 14), other (n = 2, Sri Lanka, Israel); 63.8% were clinical center studies; median study year 2000 to 2016; 87% were good quality. Among the 1,201,807 persons at risk, 242,568 persons developed NAFLD, with an incidence rate of 4,612.8 (95% CI 3,931.5-5,294.2) per 100,000 person-years and no statistically significant differences by study sample size (p = 0.90) or study setting (p = 0.055). Males had higher incidence vs. females (5,943.8 vs. 3,671.7, p = 0.0013). Both the obese (vs. non-obese) and the overweight/obese groups (vs. normal weight) were about threefold more likely to develop NAFLD (8,669.6 vs. 2,963.9 and 8,416.6 vs. 3,358.2, respectively) (both p <0.0001). Smokers had higher incidence than non-smokers (8,043.2 vs. 4,689.7, p = 0.046). By meta-regression, adjusting for study year, study setting, and study location, study period of 2010 or after and study setting were associated with increased incidence (p = 0.010 and p = 0.055, respectively). By country, China had a higher NAFLD incidence compared to non-China regions (p = 0.012) and Japan a lower incidence compared to non-Japan regions (p = 0.005). CONCLUSIONS: NAFLD incidence is increasing with a current estimate of 4,613 new cases per 100,000 person-years. Males and overweight/obese individuals had significantly higher incidence rates compared to females and those of normal weight. Public health interventions for prevention of NAFLD are needed with a special emphasis on males, overweight/obese individuals, and higher risk regions. IMPACT AND IMPLICATIONS: Non-alcoholic fatty liver disease (NAFLD) affects approximately 30% of people worldwide and appears to be increasing, but data to estimate the incidence rate are limited. In this meta-analytic study of over 1.2 million people, we estimated an incidence rate of NAFLD of 46.13 per 1,000 person-years with significant differences by sex, BMI, geography, and time-period. As treatment options for NAFLD remain limited, prevention of NAFLD should remain the focus of public health strategies. Studies such as these can help policy makers in determining which and whether their interventions are impactful.
引用
- Le MH, Le DM, Baez TC, et al. Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons. J Hepatol. 2023. PMID: 37040843. doi:10.1016/j.jhep.2023.03.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。